Posted on April 24, 2009 by cartier@bio
Josh Green, general partner at MDV-Mohr Davidow Ventures and three entrepreneurs visited Capitol Hill on Wednesday to testify before the House Small Business Committee about the need to reauthorize the SBIR program.
The Wall Street Journal’s Venture Capital Dispatch blog reported,
“Companies receiving venture funding may have other innovation in the pipeline worth [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, House Small Business Committee, SBIR, venture capital | 1 Comment »
Posted on March 31, 2009 by cartier@bio
With Congress knee-deep in legislation to help stimulate the economy and arguing over the budget, things are starting to heat up for Small Business Innovation Research (SBIR) as well. The current credit crunch has made obtaining funding for biomedical research even tougher. Researchers are facing unprecedented challenges. Unfortunately for some in biotech, slow cash flow [...]
Filed under: BIO, Congress, In the News, SBIR | Tagged: Alzheimer's, Barack Obama, Congress, NIH, Patent Baristas, SBIR | Leave a Comment »
Posted on December 10, 2008 by cartier@bio
Today we have a guest blogger. Welcome Afif Ghannoum!
In these trying economic times, biotech entrepreneurs are being put to the test to not only raise capital, but just to survive. Start-ups that a year or two ago would have been flush with capital from several sources, have been forced to closely monitor their burn rates [...]
Filed under: Congress, venture capital | Tagged: biotech, economy, entrepreneuer, SBIR, venture capitalist | 3 Comments »
Posted on October 20, 2008 by cartier@bio
Small businesses in Oklahoma have created a petition to encourage members of the Senate to remove the “hold” from this bill and to bring it to a vote.
From the Petition:
The Small Business Innovation Research (SBIR) program is currently threatened by legislative efforts in the United States Senate. A draft Senate Bill that reauthorizes the SBIR [...]
Filed under: Congress, SBIR | Tagged: Reauthorization Act, SBIR, Senate, Vote | Leave a Comment »
Posted on October 6, 2008 by cartier@bio
Buried somewhere in the middle of Friday’s first Presidential debate, Democrat Barack Obama states that:
“The third thing we have to do is we’ve got to make sure that we’re competing in education. We’ve got to invest in science and technology. China had a space launch and a space walk. We’ve got to make [...]
Filed under: In the News, SBIR | Tagged: biotech, Presidential Debate, SBIR | 1 Comment »
Posted on September 25, 2008 by cartier@bio
The Parkinson’s Action Network sent this to us for our blog:
The Parkinson’s Action Network and RetireSafe, along with 58 other organizations sent a letter to Congress urging them to take action on the SBIR Reauthorization Act this Congressional session. The Parkinson’s Action Network recognizes the unique needs of small biotechnology companies and that shrinking the [...]
Filed under: Congress, Finding Cures, SBIR, patient groups | Tagged: Congress, Parkinson's Action Network, SBIR | Leave a Comment »
Posted on September 19, 2008 by cartier@bio
Massachusetts, a state with a large emerging biotechnology company sector, continues to discuss the Small Business Innovation Research Program and who is in and who is out. With the current state of the economy, the U.S. should be working harder than ever to form successful public/private partnerships that will encourage growth and stability in the [...]
Filed under: BIO, SBIR, venture capital | Tagged: BioMed, biotech, Massachusetts, SBIR | Leave a Comment »
Posted on September 9, 2008 by cartier@bio
Welcome Back Senators! We hope you enjoyed your recess.
There is buzz that SBIR may make it on to the Senate calendar this session, but we do not have a definite date just yet. Stay tuned!
This act will increase access to early-stage funding for treatments and cures for debilitating diseases. With so many new treatments [...]
Filed under: Congress, Finding Cures, SBIR | Tagged: SBA, SBIR, Senate | Leave a Comment »
Posted on September 2, 2008 by cartier@bio
On August 22, The Boston Globe ran an editorial discussing the SBIR bill created by Senator Kennedy, stating:
Kennedy and Rudman created the program because the work of small companies was often considered too risky and too preliminary to attract venture capital money. Supporters of the program fear that the House bill will dampen the kind [...]
Filed under: Congress, In the News, SBIR, venture capital | Tagged: Congress, SBIR, Senator Kennedy | 1 Comment »
Posted on August 19, 2008 by cartier@bio
Stories are appearing nationally that highlight the importance of SBIR funding in partnership with venture capital dollars on local economies. These investment capital/government funding partnerships can foster growth in the biotech industry. This is the best way to ensure that our scientists are able to develop cutting-edge treatments and therapies and bring them to the [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, biotech, Kansas City, Kansas Enterprise Technology Corp, Rep. Graves, SBIR, Senate, Senator Bond | Leave a Comment »
